Jennison Associates
PRVL

Jennison Associates’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Jennison Associates’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-61,161
Closed -$911K – 709
2020
Q2 		$911K Buy
+61,161
New +$911K ﹤0.01% 531